AeroSafe Global
Team size: 51 - 200
Sector: Manufacturing and materials
About AeroSafe Global
Company revenue: US$ 100 - 500 million
Investors: Comerica Incorporated, Cycle Capital, Escalate Capital Partners, Hamilton Lane, WAVE Equity Partners
Company stage: Other
AeroSafe Global develops and produces aerogels and related materials for temperature-sensitive shipping needs in the United States. Its products are used in various thermal insulation applications to transport biomedical, pharmaceutical, and other temperature-sensitive products. The company provides a reliable, simple, and sustainable temperature sensitive supply chain solutions to the world’s leading biopharma companies. AeroSafe Global delivers cold-chain services for the biopharma industry that results in zero temperature excursions for every client, every product, every time. With proprietary packaging, logistics, and operational services, the company builds customized solutions that ensure the safe delivery of temperature-sensitive biopharmaceuticals.